Vol 7: Arsenic trioxide-based therapy in relapsed-refractory multiple myeloma patients: a meta-analysis and systematic review.Reportar como inadecuado



 Vol 7: Arsenic trioxide-based therapy in relapsed-refractory multiple myeloma patients: a meta-analysis and systematic review.


Vol 7: Arsenic trioxide-based therapy in relapsed-refractory multiple myeloma patients: a meta-analysis and systematic review. - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Descargar gratis o leer online en formato PDF el libro: Vol 7: Arsenic trioxide-based therapy in relapsed-refractory multiple myeloma patients: a meta-analysis and systematic review.
This article is from OncoTargets and therapy, volume 7.AbstractMultiple myeloma (MM) is a clonal malignancy characterized by the proliferation of malignant plasma cells in the bone marrow and the production of monoclonal immunoglobulin. Although some newly approved drugs (thalidomide, lenalidomide, and bortezomib) demonstrate significant benefit fo

Autor: He, Xuepeng; Yang, Kai; Chen, Peng; Liu, Bing; Zhang, Yuan; Wang, Fang; Guo, Zhi; Liu, Xiaodong; Lou, Jinxing; Chen, Huiren

Fuente: https://archive.org/







Documentos relacionados